Dr. Brad Vince & Associates Announces Award of Nearly $10 Million Contract From the National Institute on Drug Abuse (NIDA)

Published: Sep 18, 2012

(Overland Park, KS; Sept.19, 2012) – Vince & Associates Clinical Research announced it has been awarded a contract with the National Institute on Drug Abuse, part of the National Institutes of Health (NIH), to carry out clinical pharmacology studies to determine the pharmacokinetics and pharmacodynamics of new medication in humans.

This award is a five year contract with a ceiling value of $9,695,476 beginning September 2012. Vince and Associates will conduct clinical pharmacology studies to support the development of new medications for the treatment of substance abuse disorders.

“Our organization will research investigational medications to include new chemical entities, new biological products such as monoclonal antibodies, enzymes and vaccines as well as already approved drug products,” said Dr. Brad Vince, president and medical director of Vince & Associates Clinical Research. “Our organization is excited to work on clinical studies with NIDA that may benefit those struggling with substance abuse disorders.”

The project described was supported by Award # “HHSN271201200018C” from the NIDA, NIH. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIDA, NIH.

About Vince & Associates Clinical Research

Vince & Associates Clinical Research has provided clinical research services to the biopharmaceutical industry for more than a decade. The research professionals at Vince & Associates are proud to be recognized in the industry as a “Center of Research Excellence.” Vince & Associates has become a premier clinical research site by utilizing The Physician Research Model® of operation where study teams are led by highly experienced Principal Investigators intricately involved in all aspects of the clinical trial process.

Vince & Associates recently opened a state–of–the–art, multi–million dollar, 90 bed Clinical Pharmacology Unit that combines the ultimate in subject safety and luxury. Boutique hotel level amenities of the facility feature 10 uniquely designed research suites. The 20” bedside touch–screen entertainment systems allow study volunteers individual access to watch TV and movies, surf the internet or play a host of games. This new unit has the upscale atmosphere necessary for the recruitment and retention of study volunteers in both short and long–term clinical trials. From the safety and security of the controlled access unit to the added features of a movie theater and game rooms, no detail has been overlooked.

More Information

Additional background materials pertaining to Vince & Associates Clinical Research are located on the corporate website at www.vinceandassociates.com.

Back to news